A股異動 | 道氏技術漲6% 簽訂60億元碳材料項目投資合同
格隆匯4月11日丨道氏技術(300409.SZ)盤中漲6.67%,報20.16元,總市值115億元。道氏技術8日晚間公吿,道氏技術公吿,公司子公司格瑞芬擬與蘭州新區管理委員會簽署《碳材料項目合同書》,格瑞芬擬在蘭州新區新設控股子公司,投資建設“年產5000噸碳納米管粉體、3萬噸碳納米管漿料(含相關產業鏈配套)和15萬噸硅碳、石墨負極材料及石墨化加工生產項目”。項目計劃投資總額人民幣60億元,其中固定資產投資人民幣51.8億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.